{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:55:50Z","timestamp":1790286950964,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Immune checkpoint inhibitors are an integral component of oncology treatment. Adverse systemic effects of this immune modulation are often manifested in the skin and, therefore, must be carefully described and characterized to inform clinical decision making in medically complex patients. Here we report 2 cases of progressive immunotherapy-related mucocutaneous eruption that resemble Stevens\u2013Johnson Syndrome but is unique in its clinical and histopathologic presentation, supporting a distinction from classic medication-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis.<\/jats:p>","DOI":"10.1097\/dad.0000000000003083","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:00:15Z","timestamp":1753887615000},"page":"750-753","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Progressive Immunotherapy-Related Mucocutaneous Eruption: A Mimicker of SJS-TEN"],"prefix":"10.1097","volume":"47","author":[{"given":"Kishan A.","family":"Sangani","sequence":"first","affiliation":[{"name":"Pritzker School of Medicine, University of Chicago, Chicago, IL; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Lee","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liesl","family":"Schroedl","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R.","family":"Shea","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwakemi","family":"Onajin","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7986-3244","authenticated-orcid":false,"given":"Angad A.","family":"Chadha","sequence":"additional","affiliation":[{"name":"Section of Dermatology, Department of Medicine, University of Chicago, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"R1-20250919","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1158\/1078-0432.CCR-15-2872","article-title":"Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy","volume":"22","author":"Goldinger","year":"2016","journal-title":"Clin Cancer Res."},{"key":"R2-20250919","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jaad.2020.03.029","article-title":"Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: a multicenter case series","volume":"83","author":"Molina","year":"2020","journal-title":"J Am Acad Dermatol."},{"key":"R3-20250919","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","article-title":"Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN","volume":"150","author":"Morales","year":"2010","journal-title":"Am J Ophthalmol."},{"key":"R4-20250919","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","article-title":"Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"153","author":"Zimmermann","year":"2017","journal-title":"JAMA Dermatol."},{"key":"R5-20250919","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/jdv.16685","article-title":"Systemic therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a SCORTEN-based systematic review and meta-analysis","volume":"35","author":"Torres-Navarro","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R6-20250919","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J Invest Dermatol."},{"key":"R7-20250919","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12016-017-8654-z","article-title":"Current perspectives on Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"54","author":"Lerch","year":"2018","journal-title":"Clin Rev Allergy Immunol."},{"key":"R8-20250919","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41586-023-06217-y","article-title":"PD-1 maintains CD8 T cell tolerance towards cutaneous neoantigens","volume":"619","author":"Damo","year":"2023","journal-title":"Nature"},{"key":"R9-20250919","first-page":"e41439","article-title":"Pembrolizumab-associated Stevens-Johnson syndrome in a patient with metastatic non-small cell lung cancer: a case report","volume":"15","author":"Sandhu","year":"2023","journal-title":"Cureus"},{"key":"R10-20250919","doi-asserted-by":"crossref","first-page":"omac025","DOI":"10.1093\/omcr\/omac025","article-title":"Pembrolizumab-induced toxic epidermal necrolysis: case report","volume":"2022","author":"Chow","year":"2022","journal-title":"Oxford Med Case Rep."},{"key":"R11-20250919","doi-asserted-by":"crossref","first-page":"912168","DOI":"10.3389\/fonc.2023.912168","article-title":"Case report: sintilimab-induced Stevens-Johnson Syndrome in a patient with advanced lung adenocarcinoma","volume":"13","author":"Li","year":"2023","journal-title":"Front Oncol."},{"key":"R12-20250919","doi-asserted-by":"crossref","first-page":"e251233","DOI":"10.1136\/bcr-2022-251233","article-title":"Lichenoid dermatitis preceding Stevens-Johnson syndrome in a patient treated with nivolumab","volume":"15","author":"Potts","year":"2022","journal-title":"BMJ Case Rep."},{"key":"R13-20250919","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/cup.12876","article-title":"Epidermal programmed cell death-ligand 1 expression in TEN associated with nivolumab therapy","volume":"44","author":"Vivar","year":"2017","journal-title":"J Cutan Pathol."},{"key":"R14-20250919","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/1346-8138.17039","article-title":"Immune checkpoint inhibitor-induced epidermal necrolysis: a narrative review evaluating demographics, clinical features, and culprit medications","volume":"51","author":"Satoh","year":"2024","journal-title":"J Dermatol."},{"key":"R15-20250919","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00403-024-03061-6","article-title":"Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases","volume":"316","author":"Bray","year":"2024","journal-title":"Arch Dermatol Res."},{"key":"R16-20250919","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/ijd.16572","article-title":"Successful rechallenge with pembrolizumab after case of progressive immunotherapy-related mucocutaneous eruption (PIRME), a Stevens-Johnson syndrome-like reaction","volume":"62","author":"Shi","year":"2023","journal-title":"Int J Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003083","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T15:00:14Z","timestamp":1758294014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000003083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003083","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]}}}